Fertility tracker Ovuline raised $1.1 million from repeat investors Lightbank Ventures, LionBird Ltd, Bullet Time Venture, CEO Paris Wallace told MobiHealthNews. This brings the company's total announced funding to $2.5 million.
"We're going to continue the commercialization of our fertility product and continue to build and launch our pregnancy product in the next few months," Wallace said.
Ovuline offers women a way to track fertility and pregnancy through mobile apps available on iOS and Android devices. The fertility program analyzes basal body temperature, blood pressure, weight, intercourse, emotion, health, ovulation, nutrition, sleep, period, cervical fluid and steps to generate a fertility cycle and fertility score.
To track steps and weight, Ovuline devices connect to the Fitbit One, Fitbit Zip, Fitbit Aria WiFi smart scale, Withings Blood Pressure Monitor, Withings Smart Body Analyzer, and Withings Pulse. All the devices are sold in Ovuline's online store. Wallace said the company plans to offer more integrated devices and apps soon.
The pregnancy product, which will be available some time in the fourth quarter, uses blood pressure, weight, activity, emotion, sleep, baby kicks and contractions to check for potential health risks and show timelines and charts to help parents follow along with the pregnancy progression.
Wallace believes Ovuline is a "learning product" that will continue to improve as new members are added.
"We now have the 20 million data points that users have shared with us," Wallace said. "We use advanced machine learning algorithms coupled with clinical guidelines, no one else is doing this at this point."
He says they are also the only prediction platform that works for women with a regular cycle and connects to quantified self devices.